Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +20.83%
#4 Bedrock Bedrock +18.46%
#5 Nockchain Nockchain +16.07%
#6 Velvet Velvet +14.00%
#7 Fabric Protocol Fabric Protocol +13.90%
#8 Perle Perle +12.76%
#9 Starpower Starpower +12.51%
#10 Nillion Nillion +12.50%
Coin of the day
EXOD EXOD
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Rang in aandelen #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Aandeelprijs
$0.00060315
Laatst gesynchroniseerd: 2024-09-27
Marktkapitalisatie
$1.65M
Verandering (1 dag)
19.64%
Verandering (1 jaar)
0.00%
Land
SE
Handel Amniotics AB (publ) (AMNI)

Categorie

Healthcare
EPS voor Amniotics AB (publ) (AMNI)
EPS per December 2023 TTM: $-0.04
Volgens de laatste financiële rapporten en de aandelenkoers van Amniotics AB (publ) is de huidige EPS van het bedrijf (TTM) $-0.04. Eind 2022 had het bedrijf een EPS van $-0.03, een daling ten opzichte van de EPS van 2021 die $-0.04 bedroeg.
EPS-geschiedenis van Amniotics AB (publ) van 2018 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
2026 (TTM) $-0.04 -96.18%
2023 0.00 -96.18%
2022 $-0.03 -21.10%
2021 $-0.04 77.18%
2020 $-0.02 237.70%
2019 $-0.01 45.24%
2018 0.00 0.00%
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -47,293.46%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -75,685.83%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -37,429.97%
BE